Feature

Verma unveils Medicaid scorecard but refuses to judge efforts


 


“There are significant methodological issues with the underlying data, including completeness, timeliness, and quality,” the association said in a statement. It noted that most of the data come from 2015.

As expected, the data showed great variation in how states provide care, including immunizing teenagers and getting dental care to children. A big reason is that state Medicaid benefits and payments to doctors vary dramatically, the Medicaid directors said, so that “it will not be possible to make apples-to-apples comparisons between states.”

In her first public speech, Ms. Verma promised last November to release a Medicaid scorecard. She said states won’t immediately face any consequences for poor performance – but that could change.

“The data … begins to offer taxpayers insights into how their dollars are being spent and the impact those dollars have on health outcomes,” Ms. Verma said on June 4.

Pages

Recommended Reading

FDA’s Gottlieb floats ideas on Medicare drug coverage
MDedge Hematology and Oncology
ABIM, ASCO to build new pathway for maintenance of board certification
MDedge Hematology and Oncology
Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Hematology and Oncology
Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Hematology and Oncology
AMA: Opioid prescriptions down since 2013
MDedge Hematology and Oncology